Education
About Us
Working with TipRanks
Follow Us
Eris Lifesciences Ltd (IN:ERIS)
:ERIS
ERIS Stock Chart & Stats
₹1557.95
₹7.70(0.59%)
At close: 4:00 PM EST
₹1557.95
₹7.70(0.59%)
Day’s Range― - ―
52-Week Range₹1,130.05 - ₹1,909.55
Previous CloseN/A
Volume91.31K
Average Volume (3M)2.07K
Market Cap
₹212.22B
Enterprise Value₹219.64B
Total Cash (Recent Filing)₹2.05B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)51.0
Beta0.57
Next Earnings
Feb 12, 2026EPS Estimate
10.4Next Dividend Ex-DateN/A
Dividend Yield0.47%
Share Statistics
EPS (TTM)8.80
Shares Outstanding136,216,890
10 Day Avg. Volume1,915
30 Day Avg. Volume2,071
Financial Highlights & Ratios
PEG Ratio-5.23
Price to Book (P/B)6.64
Price to Sales (P/S)6.58
P/FCF Ratio20.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Eris Lifesciences Ltd News
ERIS FAQ
What was Eris Lifesciences Ltd’s price range in the past 12 months?
Eris Lifesciences Ltd lowest stock price was ₹1130.05 and its highest was ₹1909.55 in the past 12 months.
What is Eris Lifesciences Ltd’s market cap?
Eris Lifesciences Ltd’s market cap is ₹212.22B.
When is Eris Lifesciences Ltd’s upcoming earnings report date?
Eris Lifesciences Ltd’s upcoming earnings report date is Feb 12, 2026 which is in 56 days.
How were Eris Lifesciences Ltd’s earnings last quarter?
Eris Lifesciences Ltd released its earnings results on Nov 12, 2025. The company reported ₹8.8 earnings per share for the quarter, missing the consensus estimate of ₹9 by -₹0.2.
Is Eris Lifesciences Ltd overvalued?
According to Wall Street analysts Eris Lifesciences Ltd’s price is currently Overvalued.
Does Eris Lifesciences Ltd pay dividends?
Eris Lifesciences Ltd pays a Annually dividend of ₹7.35 which represents an annual dividend yield of 0.47%. See more information on Eris Lifesciences Ltd dividends here
What is Eris Lifesciences Ltd’s EPS estimate?
Eris Lifesciences Ltd’s EPS estimate is 10.4.
How many shares outstanding does Eris Lifesciences Ltd have?
Eris Lifesciences Ltd has 136,216,890 shares outstanding.
What happened to Eris Lifesciences Ltd’s price movement after its last earnings report?
Eris Lifesciences Ltd reported an EPS of ₹8.8 in its last earnings report, missing expectations of ₹9. Following the earnings report the stock price went down -1.342%.
Which hedge fund is a major shareholder of Eris Lifesciences Ltd?
Currently, no hedge funds are holding shares in IN:ERIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eris Lifesciences Ltd
Eris Lifesciences Ltd (ERIS) is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company operates primarily in the therapeutic segments of chronic and acute diseases, including diabetes, cardiovascular, and respiratory disorders. ERIS is known for its innovative formulations and has a diverse portfolio of branded generics, which include prescription medications and over-the-counter products. The company focuses on enhancing patient outcomes through effective and affordable treatment options.
Technical Analysis
Emcure Pharmaceuticals Limited
―
Gland Pharma Ltd.
―
GlaxoSmithKline Pharmaceuticals Limited
―
Glenmark Pharmaceuticals Limited
―
Sanofi Consumer Healthcare India Limited
―